TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC), Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04552509
Phase: Not Applicable
Trial Summary: The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Linda Chan, MD
Acronym:

Pin It on Pinterest